Labocanna S.A. (WSE:LCN)
Poland · Delayed Price · Currency is PLN 0.2100
-0.0060 (-2.78%)
Last updated: Aug 26, 2026, 9:10 AM CET
Labocanna Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2.59 | 2.24 | 1.01 | 0.02 | 0 | 0 | |
Revenue Growth | 67.94% | 121.74% | 6023.39% | 463.37% | 48.08% | -95.05% |
Cost of Revenue | 2.17 | 1.84 | 0.8 | 0.02 | 0.02 | 0.01 |
Gross Profit | 0.42 | 0.4 | 0.21 | -0.01 | -0.02 | -0.01 |
Selling, General & Admin | 1.07 | 1.17 | 0.97 | 0.84 | 0.4 | 0.5 |
Other Operating Expenses | -0.51 | -0.62 | -0.66 | -0.4 | -0.21 | -0.09 |
Operating Expenses | 0.62 | 0.57 | 0.32 | 0.44 | 0.19 | 0.41 |
Operating Income | -0.19 | -0.17 | -0.1 | -0.45 | -0.21 | -0.41 |
Interest Expense | -0.7 | -0.22 | -0 | -0.04 | -0.01 | -0.03 |
Interest & Investment Income | 0.02 | 0.03 | 0.05 | 0.02 | - | - |
Other Non Operating Income (Expenses) | 0.77 | 1.11 | -0 | -0 | -0.04 | -0.03 |
EBT Excluding Unusual Items | -0.11 | 0.74 | -0.05 | -0.46 | -0.27 | -0.48 |
Impairment of Goodwill | - | - | -0 | - | - | - |
Gain (Loss) on Sale of Investments | -3.27 | -1.35 | -0.39 | - | -0.97 | - |
Asset Writedown | -0.02 | - | -0.01 | -0.05 | - | -0.57 |
Other Unusual Items | - | - | - | 0.03 | 0.08 | 0.22 |
Pretax Income | -3.4 | -0.61 | -0.46 | -0.48 | -1.15 | -0.83 |
Income Tax Expense | 0.28 | 0.26 | -0.03 | 0.12 | 0.03 | -0.04 |
Earnings From Continuing Operations | -3.68 | -0.87 | -0.43 | -0.6 | -1.19 | -0.79 |
Minority Interest in Earnings | -0 | -0 | -0.01 | - | - | - |
Net Income | -3.68 | -0.87 | -0.44 | -0.6 | -1.19 | -0.79 |
Net Income to Common | -3.68 | -0.87 | -0.44 | -0.6 | -1.19 | -0.79 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 21 | 21 | 21 | 21 | 21 | 21 |
Shares Outstanding (Diluted) | 21 | 21 | 21 | 21 | 21 | 21 |
Shares Change | - | - | - | - | - | 177.09% |
EPS (Basic) | -0.17 | -0.04 | -0.02 | -0.03 | -0.06 | -0.04 |
EPS (Diluted) | -0.17 | -0.04 | -0.02 | -0.03 | -0.06 | -0.04 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.2 | -1.07 | -1.34 | -1.28 | -0.46 | -0.57 |
Free Cash Flow Per Share | -0.10 | -0.05 | -0.06 | -0.06 | -0.02 | -0.03 |
Gross Margin | 16.35% | 17.75% | 20.84% | -30.66% | - | - |
Operating Margin | -7.48% | -7.73% | -10.35% | -2700.58% | -7213.95% | -20868.33% |
Profit Margin | -142.03% | -38.90% | -43.72% | -3624.65% | -40434.52% | -39757.53% |
Free Cash Flow Margin | -84.86% | -47.58% | -132.92% | -7768.28% | -15627.63% | -28756.77% |
EBITDA | 0.01 | -0.01 | 0.07 | -0.28 | -0.05 | -0.4 |
EBITDA Margin | 0.37% | -0.66% | 7.32% | - | - | - |
D&A For EBITDA | 0.2 | 0.16 | 0.18 | 0.17 | 0.16 | 0.01 |
EBIT | -0.19 | -0.17 | -0.1 | -0.45 | -0.21 | -0.41 |
EBIT Margin | -7.48% | -7.72% | -10.35% | - | - | - |
Revenue as Reported | 2.59 | 2.24 | 1.01 | 0.02 | 0 | 0 |